Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00466804 · ClinicalTrials.gov registry record
Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 263
- Enrollment target
NCT00466804 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 263 participants.
The verdict
NCT00466804 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 263 participants
- Enrollment target
Study Summary
Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate to long-term graft survival.
Interventions
- PROCEDURE Heart transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00466804
The ClinicalTrials.gov registry entry for NCT00466804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heart transplant is the first listed.
NCT00466804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00466804 about?
NCT00466804 is a clinical study titled "Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients". Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate t...
What is the current status of trial NCT00466804?
This trial is currently completed. The enrollment target is 263 participants. The study started on 2007-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00466804?
The interventions under investigation include: Heart transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00466804?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.